| Cat. No. | Product Name | Information | 
            
                
            	| PC-21000 | AZD2014 mTOR inhibitor | Vistusertib (AZD2014) is a potent and selective dual mTORC1 and mTORC2 inhibitor, inhibits both mTORC1 and mTORC2 in vitro (pS6 (S235/236), IC50=0.2 μM, pAKT (S473) IC50=0.08 μM). | 
            
                
            	| PC-49619 | XL388 mTOR inhibitor | XL388 (XL-388) is a potent, selective and orally bioavailable mTOR inhibitor with IC50 of 9.9 nM. | 
            
                
            	| PC-49618 | RMC-6272 mTORC1 inhibitor | RMC-6272 (RMC6272) is a potent, selective bi-steric inhibitor of mTORC1 with cellular IC50 of 0.44 nM for p4EBP1 inhibition, 27-fold selectivity over mTORC2. | 
            
                
            	| PC-49617 | RMC-5552 mTORC1 inhibitor | RMC-5552 (RMC5552) is a potent, selective bi-steric inhibitor of mTORC1 with cellular IC50 of 0.48 nM for p4EBP1 inhibition, 40-fold selectivity over mTORC2. | 
            
                
            	| PC-49337 | NV-5297 mTORC1 activator | NV-5297 (NV5297) is a novel small molecule mTORC1 pathway activator, modulates the Sestrin2-Gator2 interaction and activates the mTORC1 pathway in vitro and in vivo. | 
            
                
            	| PC-38333 | BC-LI-0186 LeuRS inhibitor | BC-LI-0186 is a potent, specific inhibitor of Leucyl-tRNA synthetase (LRS), inhibits the leucine-dependent mTORC1 pathway. | 
            
                
            	| PC-38176 | NV-5138 mTORC1 activator | Mefluleucine (NV-5138, NV5138) is the first selective, orally bioavailable brain mTORC1 activator, binds to Sestrin2 (Kd=1.5 uM) and activates mTORC1 both in vitro and in vivo. | 
            
                
            	| PC-36112 | MTI-31 mTOR inhibitor | MTI-31 (LXI-15029, mTOR inhibitor-31) is a novel potent, selective mTORC1/mTORC2 inhibitor with Kd of 0.2 nM (mTOR), displays >5,000-fold selectivity over PIK3CA, PIK3CB and PIK3G. | 
            
                
            	| PC-35518 | ICSN3250 hydrochloride mTOR inhibitor | ICSN3250 (ICSN-3250) hydrochloride is a halitulin-analogue that acts as a new-class, specific mTOR inhibitor through a mechanism distinct from previous mTOR inhibitors. | 
            
                
            	| PC-35517 | ICSN3250 mTOR inhibitor | ICSN3250 (ICSN-3250) is a halitulin-analogue that acts as a new-class, specific mTOR inhibitor through a mechanism distinct from previous mTOR inhibitors. | 
            
                
            	| PC-35070 | Seco Rapamycin | Seco-rapamycin is the first in vivo open-ring metabolite of rapamycin that does not affect mTOR.. | 
            
                
            	| PC-63577 | GPI-1046 FKBP12 ligand | GPI-1046 is a non-immunosuppressive ligand of the immunophilin FKBP12. |